Company Filing History:
Years Active: 2003
Title: The Innovations of Robert W. Webster
Introduction
Robert W. Webster is a notable inventor based in Gig Harbor, WA (US). He has made significant contributions to the field of optical imaging, particularly in the detection of malignancies and diseases. His innovative work has the potential to impact early cancer detection and improve patient outcomes.
Latest Patents
Robert W. Webster holds a patent for an "Optical projection imaging system and method for automatically detecting cells with molecular marker compartmentalization associated with malignancy and disease." This system utilizes optical tomography (OT) or flow optical tomography (FOT) instruments to produce optical projection images that contain accurate density information from cells labeled with tagged molecular probes or stains. The technology includes a computer and software for analyzing and reconstructing these images into a multi-dimensional data set, along with automated feature collection and object classifiers. This invention is particularly useful for the early detection of cancers, such as lung cancer from sputum samples and cervical or ovarian cancer from cervical scrapings. Additionally, it can detect rare cells in various specimens, including blood.
Career Highlights
Robert W. Webster is associated with Visiongate, Inc., where he continues to develop and refine his innovative technologies. His work focuses on enhancing the capabilities of optical imaging systems to facilitate early cancer detection.
Collaborations
Some of his notable coworkers include Alan C. Nelson and Chee-Wui Chu, who contribute to the collaborative efforts at Visiongate, Inc. Their combined expertise fosters an environment of innovation and advancement in medical imaging technologies.
Conclusion
Robert W. Webster's contributions to optical imaging and cancer detection exemplify the impact of innovation in healthcare. His patented technology holds promise for improving early diagnosis and treatment of malignancies, ultimately benefiting patients and the medical community.